Update focuses on the evaluation, management, and monitoring of those at risk for, or living with, dyslipidemia.

Alexander B. Olawaiye, MD, shares how relacorilant’s recent approval might change the treatment landscape for ovarian cancer.

As wildfire smoke becomes an increasingly common consequence of climate change, clinicians are facing new challenges in ...

Hao Yu, PhD, discusses his team’s findings showing the 2025 immigration ban could worsen clinician shortages in underserved ...

Robert J. Fontana, MD, and Kenneth D. Rothstein, MD, share how they deliver self-management education to patients with MASLD.

Looking for a laugh? This week’s medical cartoon features a famous explorer dealing with persistent directional dysregulation ...

A novel handheld ocular cooling device produced greater reductions in chronic ocular surface pain (COSP) and improved corneal sensitivity over 8 weeks compared with a sham treatment, with no serious ...

Luana Colloca, MD, PhD, and Chris Reist, MD, comment on how clinicians can use placebo and nocebo effects to improve care.

Comprehensive smoke‑free laws covering workplaces, restaurants, and bars in the US were associated with lower county‑level cardiovascular disease (CVD) mortality rates over the 12 years after policy ...